- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT04501471
The Rural African American's Health Project (RAAFHP)
11. august 2020 opdateret af: Gene H. Brody, University of Georgia
This is an attention controlled randomized clinical trial testing the efficacy of the Strong African American Families-Teen program.
The two arm trial tests SAAF-T, a family centered brief intervention against a similarly designed program that targets nutrition and exercise.
The outcomes examined include substance use and risky sexual behavior.
Studieoversigt
Status
Afsluttet
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
In the past, African American adolescents in rural areas have avoided the high-risk behaviors prevalent among youth in urban areas.
Recent epidemiologic data, however, indicate that rural African American youth use substances and engage in high-risk sexual behavior at rates equal to or exceeding those in densely populated inner cities (Kogan, Berkel, Chen, Brody, & Murry, in press; Milhausen et al., 2003).
These risk behaviors predict HIV infection, adolescent parenthood, school dropout, involvement with the criminal justice system, and continued substance use during early adulthood (Friedman et al., 1996; Miller, Boyer, & Cotton, 2004; St. Lawrence & Scott, 1996; Tucker, Orlando, & Ellickson, 2003).
No developmentally appropriate, culturally sensitive prevention programs have been developed to deter substance use and high-risk sexual behavior among the several million African American adolescents who live in the rural South (Murry & Brody, 2004).
To address this public health need, Drs.
Brody and Murry from the University of Georgia and Drs.
DiClemente and Wingood from Emory University designed a multicomponent, family-centered prevention program, the Strong African American Families-Teen program (SAAF-T).
We conducted a randomized prevention trial to test the program's efficacy.
The sample included 502 rural African American families with a 10th-grade student, half of whom will be assigned randomly to a prevention group and half to an attention-control group.
Pre-intervention, post-intervention, and long-term follow-up assessments of adolescents' substance use and high-risk sexual behavior were gathered from the entire sample.
Specific aims were to test hypotheses that rural African American adolescents randomly assigned to participate in SAAF-T, compared to attention-control participants, will demonstrate lower rates of substance use and risky sexual behavior.
Undersøgelsestype
Interventionel
Tilmelding (Faktiske)
502
Fase
- Fase 2
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
15 år til 17 år (Barn)
Tager imod sunde frivillige
Ingen
Køn, der er berettiget til at studere
Alle
Beskrivelse
Inclusion Criteria:
- Self-identified Black or African American
- 10th grade in public school in targeted county
Exclusion Criteria:
- Unable to participate in group-based intervention due to mental health
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Forebyggelse
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Dobbelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: SAAF-T
Participants received a 5 session, 10-hour family centered prevention program designed to prevent substance use, conduct problems, and risky sexual behavior
|
Parents and youth meet separately during first hour to engage in activities then meet in family groups during the second hours of each session.
Andre navne:
|
|
Placebo komparator: Fuel for Families
Participants received a 5 session, 10 hour family centered program that focused on healthy nutrition and exercise.
|
Parents and youth meet separately during first hour to engage in activities then meet in family groups during the second hours of each session.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Substance Use
Tidsramme: Follow up period baseline to 22 months post-baseline
|
Index of alcohol, cigarette, and marijuana use in the past 3 months
|
Follow up period baseline to 22 months post-baseline
|
|
Risky Sexual Behavior
Tidsramme: Follow up period baseline to 22 months post-baseline
|
Count of unprotected intercourse
|
Follow up period baseline to 22 months post-baseline
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Depressive symptomology- CES-D Scale
Tidsramme: Symptoms in past week assessed, follow up period includes baseline to 22 months post baseline
|
Symptoms of depression, 20 items
|
Symptoms in past week assessed, follow up period includes baseline to 22 months post baseline
|
|
Conduct Problems
Tidsramme: Follow up period baseline to 22 months post-baseline
|
Using 14 questions from the National Youth Survey,adolescents indicated the frequency during the past 6 months with which they had fought, stolen, been truant from school, or been suspended from school.
Adolescents' responses were summed, and the sum constituted the conduct problems score.13
|
Follow up period baseline to 22 months post-baseline
|
Andre resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Discussion Quality Scale
Tidsramme: Follow up period -baseline to 6 month posttest
|
The DQS assessed communication frequency and quality for discussions of difficult issues.
|
Follow up period -baseline to 6 month posttest
|
|
Family Support Inventory
Tidsramme: Follow up period -baseline to 6 month posttest
|
The FSI measured provision of emotional support, involvement, and quality of caregiver-youth communication
|
Follow up period -baseline to 6 month posttest
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Publikationer og nyttige links
Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Faktiske)
1. september 2005
Primær færdiggørelse (Faktiske)
1. september 2010
Studieafslutning (Faktiske)
1. september 2010
Datoer for studieregistrering
Først indsendt
3. august 2020
Først indsendt, der opfyldte QC-kriterier
3. august 2020
Først opslået (Faktiske)
6. august 2020
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
14. august 2020
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
11. august 2020
Sidst verificeret
1. august 2020
Mere information
Begreber relateret til denne undersøgelse
Andre undersøgelses-id-numre
- 2006-10685
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Ingen
IPD-planbeskrivelse
There is no plan to share data
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ingen
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ingen
produkt fremstillet i og eksporteret fra U.S.A.
Ingen
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med SAAF-T
-
National Cancer Institute (NCI)AfsluttetPerifert T-celle lymfom (PTCL) | T-celle prolymfocytisk leukæmi | Kutan T-celle lymfom (CTCL) | T-celle lymfom tilbagefald | Voksen T-celleleukæmi (ATL)Forenede Stater
-
University of Alabama at BirminghamAfsluttetAnaplastisk storcellet lymfom | Angioimmunoblastisk T-celle lymfom | Perifere T-celle lymfomer | Voksen T-celle leukæmi | Voksen T-celle lymfom | Perifert T-celle lymfom Uspecificeret | T/Nulcelle systemisk type | Kutan t-celle lymfom med nodal/visceral sygdomForenede Stater
-
National Cancer Institute (NCI)Trukket tilbageHepatosplenisk T-celle lymfom | Enteropati-associeret T-celle lymfom | Voksen T-celle leukæmi/lymfom | Ekstranodal NK-/T-celle lymfom, nasal type | Monomorft epiteliotrofisk tarm T-celle lymfomForenede Stater
-
Washington University School of MedicineWugen, Inc.Aktiv, ikke rekrutterendeAkut myeloid leukæmi | Sezary syndrom | Anaplastisk storcellet lymfom | Angioimmunoblastisk T-celle lymfom | Voksen T-celle leukæmi | Voksen T-celle lymfom | Hepatosplenisk T-celle lymfom | Perifert T-celle lymfom | Ekstranodal NK/T-celle lymfom | Enteropati-associeret T-celle lymfom | T-celle non-Hodgkin lymfom og andre forholdForenede Stater
-
Jonsson Comprehensive Cancer CenterRekrutteringT-celle-prolymfocytisk leukæmi | Kutan T-celle lymfom refraktærForenede Stater
-
Seattle Children's HospitalIkke rekrutterer endnuBil T -celle | Bil T -celleterapiForenede Stater
-
The First Affiliated Hospital with Nanjing Medical...Nanjing Legend Biotechnology Co. The First Affiliated Hospital of USTC...AfsluttetCD4+ T-lymfocyttumor (T-cellelymfom og T-celleleukæmi)Kina
-
University of NebraskaNational Cancer Institute (NCI); AmgenAfsluttetPerifert T-celle lymfom | Anaplastisk storcellet lymfom | Angioimmunoblastisk T-celle lymfom | Voksen Nasal Type Ekstranodal NK/T-celle lymfom | Tilbagevendende voksen T-celle leukæmi/lymfomForenede Stater
-
Novartis PharmaceuticalsAfsluttetLeukæmi-lymfom, voksen T-celle | Kutant T-celle lymfomJapan
-
Kyowa Kirin Co., Ltd.AfsluttetVoksen T-celle leukæmi og lymfom (ATL) | Voksen perifert T-celle lymfom (PTCL)Japan
Kliniske forsøg med SAAF-T
-
University of GeorgiaAfsluttetUngdoms alkoholbrug
-
University of GeorgiaRekruttering
-
Biotronik SE & Co. KGAfsluttetHjertefejl | BradykardiDanmark, Hong Kong, Østrig, Tyskland, Belgien
-
Shenzhen Salubris Pharmaceuticals Co., Ltd.Ikke rekrutterer endnu
-
Sun Yat-sen UniversityAktiv, ikke rekrutterende
-
Shanghai Zhongshan HospitalRekruttering
-
Biotronik SE & Co. KGAfsluttetVentrikulær fibrillation | Ventrikulær takykardiTyskland, Tjekkiet
-
Children's Hospital Medical Center, CincinnatiEunice Kennedy Shriver National Institute of Child Health and Human Development... og andre samarbejdspartnereRekrutteringAutismespektrumforstyrrelseForenede Stater
-
Xuanwu Hospital, BeijingBioray LaboratoriesIkke rekrutterer endnuMultipel sclerose | Neuromyelitis Optica Spectrum Disorders | Kronisk inflammatorisk demyeliniserende polyradiculoneuropati | Myasthenia Gravis, generaliseretKina
-
University of California, BerkeleyUniversity of Nevada, Reno; World BankAfsluttetDen tidlige barndoms udviklingMadagaskar